Volume 5, Issue 3 pp. 168-175
Full Access

Measuring quality of life in oncology: is it worthwhile? II. Experiences from the treatment of cancer

ALI MONTAZERI BSc, MPH

Corresponding Author

ALI MONTAZERI BSc, MPH

PhD candidate

Department of Public Health, University of Glasgow, Scotland, UK

address: Ali Montazeri, 2 Lilybank Gardens, Department of Public Health, University of Glasgow, Glasgow G12 8RZ, Scotland, UK.Search for more papers by this author
CHARLES R. GILLIS MD, FRCP (Glas), FFPHM

CHARLES R. GILLIS MD, FRCP (Glas), FFPHM

Director

West of Scotland Cancer Surveillance Unit, Ruchill Hospital, Glasgow, Scotland, UK

Search for more papers by this author
JAMES McEWEN FRCP(Glas), FFPHM

JAMES McEWEN FRCP(Glas), FFPHM

Professor and Head

Department of Public Health, University of Glasgow, Scotland, UK

Search for more papers by this author
First published: September 1996
Citations: 16

Abstract

This is the second part of the paper on quality of life in cancer patients which appeared in this journal (Montazeri et al., 1996a). In this part experiences from the treatment of cancer are given and relevant literature is reviewed. Several topics have been covered, including new directions and methods in assessing quality of life. It is argued that in a chronic condition, adding life to years instead of years to life is an important task. Adding years to life may prolong survival, but whether this is to the benefit of patients is debatable. Considering patients' views, their values and preferences may improve the quality of care and at the same time, reduce the psychological distress and physical discomfort in patients with cancer. It is concluded that quality of life measures have considerable potential in this challenging issue.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.